MedPath

Trial and Cost Effectiveness Evaluation of Intra-arterial Thrombectomy in Acute Ischemic Stroke

Not Applicable
Terminated
Conditions
Cerebral Stroke
Cerebrovascular Accident
Interventions
Procedure: Mechanic thrombectomy (MERCI, PENUMBRA, CATCH, SOLITAIRE)
Registration Number
NCT01062698
Lead Sponsor
Central Hospital, Nancy, France
Brief Summary

THRACE is a controled, multicenter and randomized trial.

The primary objective of this study is to determine whether a combined approach intravenous thrombolysis (IV) + Mechanical thrombectomy is superior to the reference treatment with IV thrombolysis alone, in the 3 hours of onset of symptoms in patients with occlusion of proximal cerebral arteries and with a neurological impairment accident (National Institutes of Health Stroke Scale \[NIHSS\] ≥ 10).

The second objective is to determine the cost-effectiveness of this procedure compared to the standard (IV thrombolysis). The assumption is that the combined approach, by improving the clinical outcome and speed recovery, allows for lower overall costs to the IV thrombolysis in 3 months and less than or at worst neutral to 1 year.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
412
Inclusion Criteria
  • 10<=NIHSS Score=<25
  • Symptoms onset less than 4 hours
  • Occlusion of the intracranial carotid, the middle cerebral artery (M1) or the upper third of the basilar
Exclusion Criteria
  • Contraindications for intravenous thrombolysis
  • Occlusion or stenosis of the pre-occlusive cervical internal carotid artery ipsilateral to the lesion
  • Any cause local prohibiting femoral catheterization

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
IV thrombolysis + thrombectomyAlteplase (rt-PA)/Actilyse-
IV thrombolysis + thrombectomyMechanic thrombectomy (MERCI, PENUMBRA, CATCH, SOLITAIRE)-
IV thrombolysisAlteplase (rt-PA)/Actilyse-
Primary Outcome Measures
NameTimeMethod
Modified Rankin Score (mRs )3 months after treatment
Secondary Outcome Measures
NameTimeMethod
Quality of Life (Euroqol EQ-5D)3 months after treatment
Barthel Score3 months after treatment

Trial Locations

Locations (1)

Central Hospital Nancy (Central HNF)

🇫🇷

Nancy, France

© Copyright 2025. All Rights Reserved by MedPath